1. Home
  2. >Arpeggio Bio
Arpeggio Bio logo

Arpeggio Bio

Arpeggio Bio develops drugs targeting transcription factors using AI…

Company

Locations
Boulder, CO, USA
Team Size
20
Industries
Healthcare, Drug Discovery and Delivery
About
Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.

Founders

A list of all active founders
NameTitleEmail
Joey Azofeifa
Founder